Application of perilla frutescens in preparation of medicine for inhibiting novel coronavirus
By mixing pulverized perilla nanoparticles with an oil-water bilayer liquid to create an oral powder spray formulation, the problem of the lack of effective treatment for the novel coronavirus has been solved, achieving highly efficient inhibition and therapeutic effects.
Patent Information
- Application Number
- CN202310603855.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-26
- Publication Date
- 2024-11-26
AI Technical Summary
Currently, there are no effective drugs for treating and preventing the novel coronavirus COVID-19, and existing treatments mainly rely on supportive therapies.
An oral powder spray formulation was prepared by mixing 6000-mesh perilla nanoparticles after pulverization and cell wall breaking with an oil-water bilayer liquid. This formulation is used to inhibit the novel coronavirus SARS-CoV-2 and contains surfactants, licorice oil extract, angelica extract, and herbal essential oils.
It achieved a 99.9% inhibition rate against the novel coronavirus and provided drug solutions for the treatment and prevention of related diseases.
Smart Images

Figure CN119015348A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of biology or medicine technology, and in particular to an application of perilla in the preparation of a drug for inhibiting the new coronavirus. Background Art
[0002] In 2020, the World Health Organization called the disease caused by the new coronavirus COVID-19 (Coronavirus Disease-2019), and the International Association for Taxonomy of Virology named the virus SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). The new coronavirus SARS-CoV-2 belongs to the beta subfamily (betacoronavirus) of the Coronavirinae family; the Coronavirinae (CoV) is a group of single-stranded positive-strand RNA viruses with an envelope, which are round in appearance and named after the crown-like protrusions that can be seen under an electron microscope.
[0003] Research data shows that when SARS-CoV-2 infected people breathe, talk, sing, exercise, cough or sneeze, they release droplets of varying sizes containing the virus. Small droplet nuclei can remain suspended in the air for minutes to hours, while larger droplets will settle quickly and may stay on the ground or on the surface of objects, allowing the virus to be transmitted through inhalation, direct or indirect contact. In addition, confirmed patients may be contagious 2 days before the onset of the disease, and confirmed patients continue to excrete respiratory viruses after the onset of the disease.
[0004] Currently, there is no specific recommended treatment for patients infected with the novel coronavirus, and supportive therapy is mostly used clinically. Therefore, there is an urgent need to develop drugs that can effectively inhibit the novel coronavirus COVID-19. Summary of the invention
[0005] The purpose of the present invention is to provide a new use of perilla nano powder with a particle size of 6000 mesh after crushing and wall breaking in the preparation of drugs for inhibiting the new coronavirus.
[0006] To achieve the above-mentioned purpose, the use of Perilla frutescens of the present invention in the preparation of a drug for inhibiting the new coronavirus is achieved by the following techniques:
[0007] A use of perilla in preparing a drug for inhibiting the new coronavirus, comprising using perilla nanopowder with a particle size of 6000 mesh after crushing and wall breaking to prepare an inhibitor for inhibiting the new coronavirus (SARS-CoV-2, Omincron variant); and / or a drug for treating and / or preventing and alleviating related diseases caused by infection with the new coronavirus (SARS-CoV-2, Omincron variant).
[0008] The use of the perilla as described above in the preparation of a drug for inhibiting the new coronavirus, wherein the drug is an oral powder spray preparation.
[0009] The use of perilla as described above in the preparation of a drug for inhibiting the new coronavirus, wherein the perilla fine powder and the oil-water double-layer liquid are mixed in a ratio of 1:100 (wt%) to form a liquid perilla composition; the oil-water double-layer liquid comprises a lower layer liquid and an upper layer liquid, the ratio between the lower layer liquid and the upper layer liquid is 28:4 (wt%), and the upper layer liquid has a smaller specific gravity than the lower layer liquid.
[0010] The use of Perilla as described above in the preparation of a drug for inhibiting the new coronavirus, wherein the lower layer liquid is a liquid containing a surfactant.
[0011] The use of perilla as described above in the preparation of a drug for inhibiting the new coronavirus, wherein the upper layer liquid comprises an extract of oil-extracted licorice, angelica and herbal essential oil, the ratio of the extract of oil-extracted licorice, angelica to the herbal essential oil is 1:1 (wt%), and the herbal essential oil components comprise cedar, schizonepeta, mint, ylang-ylang and neroli.
[0012] A method for inhibiting the new coronavirus (SARS-CoV-2, Omincron variant), comprising administering an inhibitor containing perilla fine powder to a subject in need; wherein the perilla fine powder can inhibit the new coronavirus (SARS-CoV-2, Omincron variant).
[0013] The method for inhibiting the new coronavirus (SARS-CoV-2, Omincron variant) as described above, wherein the inhibitor is an oral powder spray preparation. BRIEF DESCRIPTION OF THE DRAWINGS
[0014] Figure 1 This is a graph (I) showing the particle size of perilla powder under a scanning electron microscope magnified 5000 times according to the present invention.
[0015] Figure 2 This is the particle size detection diagram of the perilla powder under the scanning electron microscope magnified 5000 times of the present invention (II).
[0016] Figure 3 This is the particle size detection diagram of the perilla powder under the scanning electron microscope magnified 5000 times of the present invention (III).
[0017] Figure 4 This is a diagram showing the results of the virus plaque assay of the present invention. DETAILED DESCRIPTION
[0018] In order to make the technical content, invention purpose and effect achieved by the present invention more complete and clear, the following is a detailed description:
[0019] A drug for inhibiting the novel coronavirus, comprising perilla nanopowder, wherein the perilla nanopowder is a nanopowder with a particle size of 6000 mesh after being crushed and broken by a dry pulverizer. The drug can be used to prepare an inhibitor for inhibiting the novel coronavirus (SARS-CoV-2, Omincron variant); and / or a drug for treating and / or preventing and alleviating related diseases caused by infection with the novel coronavirus (SARS-CoV-2, Omincron variant); and is an oral powder spray preparation.
[0020] The preparation of perilla nano powder is to select the whole perilla including roots, stems and leaves, wash and dry them, and then break the wall and grind them into powder, and the particle size after grinding reaches 6000 meshes.
[0021] The ultrafine grinding and wall breaking of dried perilla to reach nanometer particle size is carried out by using a "air flow pulverizer". The principle of the "air flow pulverizer" is that when the dried perilla raw material enters the pulverizing chamber of the air flow pulverizer, ultra-high-speed airflow is sprayed through several air flow nozzles in the pulverizing chamber, and the dried perilla is impacted by the high-speed airflow and collides with each other, so that the dried perilla is crushed to a perilla powder with a particle size of 6000 mesh, and the purpose of physical wall breaking is achieved at the same time. Among them, the technology of the "air flow pulverizer" is cited from the US patent case US 7472852 B2.
[0022] Since the particle size of perilla powder reaches 6000 mesh nanometer level and is in a broken wall state, the human body can fully absorb the effective substances contained in perilla.
[0023] Please see Figure 1-Figure 3 The particle size of the perilla powder after ultrafine grinding and wall breaking by air flow mill was observed by scanning electron microscope at 5000 times magnification. Figure 1-Figure 3 It can be seen that the particle size of the perilla powder after ultrafine grinding and wall breaking is less than 8 microns, and D50 is 2 to 5 microns.
[0024] In addition, the virus plaque assay was used to test whether the ultrafinely crushed perilla powder had an inhibitory effect on the new coronavirus (SARS-CoV-2, Omincron variant); wherein the ultrafinely crushed perilla powder accounting for 1wt% of the culture medium was used, the test cells were Vero C1008 [Vero 76, clone E6, VeroE6] CRL-1586, and the test reaction time was 30 seconds; the test results are as follows Figure 4 As shown by Figure 4 The test results show that ultra-finely crushed perilla powder has a 99.9% inhibitory effect on the new coronavirus (SARS-CoV-2, Omincron variant).
[0025] The present invention mixes the wall-broken perilla powder with a particle size of 6000 meshes with an oil-water double-layer liquid at a ratio of 1:100 (wt%) to form a liquid perilla composition; in one embodiment, the liquid perilla composition can be contained in a spray bottle and used in the form of a spray.
[0026] In one embodiment, the oil-water bilayer liquid comprises a lower layer liquid and an upper layer liquid, the ratio between the lower layer liquid and the upper layer liquid is 28:4 (wt%), and the specific gravity of the upper layer liquid is less than that of the lower layer liquid, so that when the liquid perilla composition is in a static state, the upper layer liquid is suspended on the lower layer liquid.
[0027] In one embodiment, the lower layer liquid is a liquid containing a surfactant, and when the liquid perilla composition is placed in a container and shaken, the upper layer liquid and the lower layer liquid can be mixed briefly.
[0028] Furthermore, in one embodiment, the upper layer liquid comprises an extract of oil-extracted licorice, angelica and herbal essential oil, the ratio of the extract of oil-extracted licorice, angelica to the herbal essential oil is 1:1 (wt%), and the herbal essential oil components include cedar, schizonepeta, mint, ylang-ylang and neroli.
Claims
1. A use of perilla in preparing a drug for inhibiting the new coronavirus, which comprises using perilla nanopowder with a particle size of 6000 mesh after crushing and breaking the wall to prepare an inhibitor for inhibiting the new coronavirus (SARS-CoV-2, Omincron variant); and / or a drug for treating and / or preventing and alleviating related diseases caused by infection with the new coronavirus (SARS-CoV-2, Omincron variant).
2. The use of Perilla frutescens according to claim 1 in preparing a drug for inhibiting the new coronavirus, wherein: The medicine is an oral powder spray preparation.
3. The use of Perilla frutescens according to claim 2 in the preparation of a drug for inhibiting the new coronavirus, wherein: The perilla fine powder and the oil-water double-layer liquid are mixed in a ratio of 1:100 (wt%) to form a liquid perilla composition; the oil-water double-layer liquid comprises a lower layer liquid and an upper layer liquid, the ratio between the lower layer liquid and the upper layer liquid is 28:4 (wt%), and the upper layer liquid has a smaller specific gravity than the lower layer liquid.
4. The use of Perilla frutescens according to claim 3 in preparing a drug for inhibiting the new coronavirus, wherein: The lower layer liquid is a liquid containing a surfactant.
5. The use of Perilla frutescens according to claim 4 in preparing a drug for inhibiting the new coronavirus, wherein: The upper layer liquid comprises extracts of oil-extracted licorice and angelica and herbal essential oils, the ratio of the extracts of oil-extracted licorice and angelica to the herbal essential oils is 1:1 (wt%), and the herbal essential oil components comprise cedar, nepeta, mint, ylang-ylang and neroli.
6. The use of Perilla frutescens according to claim 1 in preparing a drug for inhibiting the new coronavirus, wherein: The perilla fine powder and the oil-water double-layer liquid are mixed in a ratio of 1:100 (wt%) to form a liquid perilla composition; the oil-water double-layer liquid comprises a lower layer liquid and an upper layer liquid, the ratio between the lower layer liquid and the upper layer liquid is 28:4 (wt%), and the upper layer liquid has a smaller specific gravity than the lower layer liquid.
7. The use of Perilla frutescens according to claim 6 in preparing a drug for inhibiting the new coronavirus, wherein: The lower layer liquid is a liquid containing a surfactant.
8. The use of Perilla frutescens according to claim 7 in preparing a drug for inhibiting the new coronavirus, wherein: The upper layer liquid comprises extracts of oil-extracted licorice and angelica and herbal essential oils, the ratio of the extracts of oil-extracted licorice and angelica to the herbal essential oils is 1:1 (wt%), and the herbal essential oil components comprise cedar, nepeta, mint, ylang-ylang and neroli.
9. A method for inhibiting the new coronavirus (SARS-CoV-2, Omincron variant), comprising administering an inhibitor containing Perilla frutescens powder to a subject in need; wherein the Perilla frutescens powder can inhibit the new coronavirus (SARS-CoV-2, Omincron variant).
10. The method for inhibiting SARS-CoV-2 (Omincron variant) according to claim 9, wherein: The inhibitor is an oral powder spray preparation.
Citation Information
Patent Citations
Method for fining powder and apparatus employing the same
US7472852B2
Method against coronavirus infection with water-extracted product of perilla frutescens
TW202211929A
